KPIs & Operating Metrics(New)
Growth Metrics

Medtronic (MDT) Shares Outstanding (Weighted Average) (2016 - 2026)

Medtronic's Shares Outstanding (Weighted Average) history spans 14 years, with the latest figure at $1.3 billion for Q1 2026.

  • On a quarterly basis, Shares Outstanding (Weighted Average) changed 0.36% to $1.3 billion in Q1 2026 year-over-year; TTM through Jan 2026 was $1.3 billion, a 0.36% change, with the full-year FY2025 number at $1.3 billion, down 3.17% from a year prior.
  • Shares Outstanding (Weighted Average) hit $1.3 billion in Q1 2026 for Medtronic, roughly flat from $1.3 billion in the prior quarter.
  • Over the last five years, Shares Outstanding (Weighted Average) for MDT hit a ceiling of $1.3 billion in Q1 2022 and a floor of $1.3 billion in Q3 2025.
  • Historically, Shares Outstanding (Weighted Average) has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2022.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): rose 0.08% in 2023 and later fell 3.23% in 2025.
  • Tracing MDT's Shares Outstanding (Weighted Average) over 5 years: stood at $1.3 billion in 2022, then rose by 0.07% to $1.3 billion in 2023, then fell by 3.13% to $1.3 billion in 2024, then dropped by 0.53% to $1.3 billion in 2025, then increased by 0.02% to $1.3 billion in 2026.
  • Business Quant data shows Shares Outstanding (Weighted Average) for MDT at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.